Camerin Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
as on 17-12-2024
- Paid Up Capital ₹ 1.99 Cr
as on 17-12-2024
- Company Age 45 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 9.09 M
as on 17-12-2024
- Satisfied Charges ₹ 1.40 M
as on 17-12-2024
- Revenue -95.67%
(FY 2018)
- Profit -182.39%
(FY 2018)
- Ebitda -253.68%
(FY 2018)
- Net Worth -3.75%
(FY 2018)
- Total Assets -64.77%
(FY 2018)
About Camerin Drugs And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 1.99 Cr.
The company currently has active open charges totaling ₹9.09 M. The company has closed loans amounting to ₹1.40 M, as per Ministry of Corporate Affairs (MCA) records.
Abdul Mailanchikal, Mailachikkal Ahamed, and Jihan Abdulla serve as directors at the Company.
- CIN/LLPIN
U24231KL1979PLC003115
- Company No.
003115
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Nov 1979
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kannur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Camerin Drugs And Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abdul Mailanchikal  | Director | 23-May-1997 | Current |
| Mailachikkal Ahamed | Director | 11-Jun-2007 | Current |
| Jihan Abdulla | Director | 19-Nov-2004 | Current |
Financial Performance and Corporate Structure Insights of Camerin Drugs And Pharmaceuticals.
Camerin Drugs And Pharmaceuticals Ltd, for the financial year ended 2018, experienced significant reduction in revenue, with a 95.67% decrease. The company also saw a substantial fall in profitability, with a 182.39% decrease in profit. The company's net worth dipped by a decrease of 3.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Camerin Drugs And Pharmaceuticals?
In 2018, Camerin Drugs And Pharmaceuticals had a promoter holding of 0.05% and a public holding of 99.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Real Forts And Resorts Pvt LtdActive 31 years 3 months
Abdul Mailanchikal and Jihan Abdulla are mutual person
- Agreenco Fruit Products Private LimitedActive 21 years 8 months
Mailachikkal Ahamed is a mutual person
- Bravo International Trading Private LimitedActive 16 years 5 months
Jihan Abdulla is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 01 Sep 2004 | ₹4.00 M | Open |
Syndicate Bank Creation Date: 20 Mar 1990 | ₹2.10 M | Open |
Kerala Financial Corporation Creation Date: 25 Apr 1983 | ₹0.08 M | Open |
How Many Employees Work at Camerin Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Camerin Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Camerin Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Camerin Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
